The Vistria Group, a private investment firm, completed the investment in Ora, an ophthalmic contract research organization. Financial terms were not disclosed. “Ora is a leader in ophthalmic clinical research, and we are delighted to partner with the Ora team in the next chapter of its growth. We invested in Ora because of its strong globally recognized brand, demonstrated innovation, service excellence, and tenured team of ophthalmology veterans, many who have worked together for decades, leading to an unparalleled record bringing over 85 drugs and devices to market. We are excited to build on Ora’s track record of success of partnering with customers and bringing new life-enhancing treatments to patients around the world,” Natasha Latif, The Vistria Group Partner for Healthcare.